NZ177508A - Cephalosporin derivatives and antibiotic compositions - Google Patents

Cephalosporin derivatives and antibiotic compositions

Info

Publication number
NZ177508A
NZ177508A NZ177508A NZ17750875A NZ177508A NZ 177508 A NZ177508 A NZ 177508A NZ 177508 A NZ177508 A NZ 177508A NZ 17750875 A NZ17750875 A NZ 17750875A NZ 177508 A NZ177508 A NZ 177508A
Authority
NZ
New Zealand
Prior art keywords
cephalosporin derivatives
antibiotic compositions
antibiotic
compositions
cephalosporin
Prior art date
Application number
NZ177508A
Other languages
English (en)
Inventor
M Montavon
R Reiner
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NZ177508A publication Critical patent/NZ177508A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ177508A 1974-06-21 1975-05-13 Cephalosporin derivatives and antibiotic compositions NZ177508A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH853774A CH609989A5 (en) 1974-06-21 1974-06-21 Process for the preparation of acyl derivatives

Publications (1)

Publication Number Publication Date
NZ177508A true NZ177508A (en) 1978-04-03

Family

ID=4341690

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ177508A NZ177508A (en) 1974-06-21 1975-05-13 Cephalosporin derivatives and antibiotic compositions

Country Status (25)

Country Link
JP (1) JPS625917B2 (da)
AT (1) AT337897B (da)
AU (1) AU498387B2 (da)
BE (1) BE830455A (da)
BR (1) BR7503782A (da)
CA (1) CA1111021A (da)
CH (1) CH609989A5 (da)
CU (1) CU34293A (da)
DD (1) DD121113A5 (da)
DE (1) DE2527291A1 (da)
DK (2) DK153155C (da)
FI (1) FI751815A (da)
FR (1) FR2275215A1 (da)
GB (1) GB1471804A (da)
HU (1) HU170576B (da)
IE (1) IE41888B1 (da)
IL (1) IL47299A (da)
LU (1) LU72771A1 (da)
NL (1) NL180665C (da)
NO (1) NO752202L (da)
NZ (1) NZ177508A (da)
PH (1) PH13030A (da)
SE (1) SE431755B (da)
SU (2) SU635873A3 (da)
ZA (1) ZA753086B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7805715A (nl) * 1977-06-03 1978-12-05 Hoffmann La Roche Werkwijze voor het bereiden van acylderivaten.
JPS5419990A (en) * 1977-07-14 1979-02-15 Shionogi & Co Ltd Dihydrotriazinylthioxacephalosporin
MC1259A1 (fr) * 1978-05-30 1980-01-14 Hoffmann La Roche Derives acyles
FR2474030A1 (fr) * 1980-01-17 1981-07-24 Rhone Poulenc Ind Nouvelles dioxotriazines et leur preparation
FR2494278A1 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine, leurs preparations et les medicaments qui les contiennent
CN1531539A (zh) * 2001-04-19 2004-09-22 ��ŷ�����¶����ǹɷ����޹�˾ 用α-酮酸衍生物制备头孢烷酸衍生物的酶促方法
KR101637381B1 (ko) 2008-03-05 2016-07-07 메르크 파텐트 게엠베하 인슐린 분비 자극제들로서의 피라지논 유도체들, 이들을 얻기 위한 방법들 및 당뇨병 치료를 위한 이들의 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868369A (en) * 1972-11-14 1975-02-25 Smithkline Corp 3-heterocyclicthiomethylcephalosporins

Also Published As

Publication number Publication date
DK153155C (da) 1988-10-31
DD121113A5 (da) 1976-07-12
ZA753086B (en) 1976-04-28
ATA476975A (de) 1976-11-15
SE431755B (sv) 1984-02-27
IE41888L (en) 1975-12-21
BR7503782A (pt) 1976-07-06
HU170576B (da) 1977-07-28
JPS5113793A (da) 1976-02-03
JPS625917B2 (da) 1987-02-07
GB1471804A (en) 1977-04-27
IL47299A0 (en) 1976-10-31
CA1111021A (en) 1981-10-20
IL47299A (en) 1979-01-31
AU8191275A (en) 1976-12-09
DK153155B (da) 1988-06-20
NL180665C (nl) 1987-04-01
DK453687D0 (da) 1987-08-28
FR2275215A1 (fr) 1976-01-16
LU72771A1 (da) 1977-03-04
SU635873A3 (ru) 1978-11-30
NO752202L (da) 1975-12-23
IE41888B1 (en) 1980-04-23
CH609989A5 (en) 1979-03-30
SU589921A3 (ru) 1978-01-25
DK271975A (da) 1975-12-22
AT337897B (de) 1977-07-25
DK453687A (da) 1987-08-28
CU34293A (es) 1979-01-16
NL180665B (nl) 1986-11-03
DE2527291C2 (da) 1988-01-14
NL7507390A (nl) 1975-12-23
SE7506908L (sv) 1975-12-22
BE830455A (fr) 1975-12-22
DK155329C (da) 1989-08-07
DK155329B (da) 1989-03-28
DE2527291A1 (de) 1976-01-08
PH13030A (en) 1979-11-15
FI751815A (da) 1975-12-22
FR2275215B1 (da) 1980-05-16
AU498387B2 (en) 1979-03-08

Similar Documents

Publication Publication Date Title
HK60480A (en) Antibiotic azetidinopyrrole derivative
IL48341A0 (en) 3-thio-substituted cephalosporin antibiotics
IL48020A0 (en) Novel cephalosporin derivatives and their preparation
GB1483416A (en) Cephalosporin derivative and its preparation
PH12058A (en) Antibiotic pharmaceutical compositions
IL47670A0 (en) Antibiotic a2041 derivatives
NZ177508A (en) Cephalosporin derivatives and antibiotic compositions
AU500890B2 (en) Ergolene and ergoline derivatives
IE41150L (en) Cephalosporin derivatives
GB1487658A (en) Cephalosporin derivative
NZ179598A (en) Cephalosporins and pharmaceutical compositions
PH11072A (en) Cephalosporin antibiotics
IL47348A0 (en) Cephalosporin and penicillin derivatives
PH12314A (en) Benzylpyrimidines derivatives and antibacterial composition thereof
PH12782A (en) Z-hydroxy-w-aminoalkyl derivatives of aminoglycoside antibiotics
PH10810A (en) Cephalosporin derivatives and antibacterial compositions containing them
GB1482493A (en) Beta-lactam derivatives
IL45877A (en) 4-oxo-1-pyridinyl-penicillin and cephalosporin derivatives
EG12248A (en) Alkylated derivatives of antibiotic bm123
IL46956A0 (en) Ureido substituted cephalosporin antibiotics
GB1484616A (en) Tetrazolymethylthioacetyl cephalosporin derivatives
ZA754163B (en) Cephalosporin derivatives their preparation and compositions containing them
AU8264775A (en) Cephalosporin derivatives their preparation and compositions containing them
AU489765B2 (en) Cephalosporin derivatives
AU479231B2 (en) Cephalosporin derivatives